Free Trial

MQS Management LLC Invests $502,000 in Henry Schein, Inc. (NASDAQ:HSIC)

Henry Schein logo with Medical background

MQS Management LLC bought a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm bought 7,327 shares of the company's stock, valued at approximately $502,000.

A number of other large investors also recently bought and sold shares of HSIC. Palestra Capital Management LLC acquired a new stake in shares of Henry Schein during the 4th quarter worth approximately $182,988,000. Lyrical Asset Management LP acquired a new stake in shares of Henry Schein during the 4th quarter worth approximately $126,655,000. Norges Bank acquired a new stake in shares of Henry Schein during the 4th quarter worth approximately $103,301,000. Steadfast Capital Management LP raised its position in shares of Henry Schein by 254.2% during the 4th quarter. Steadfast Capital Management LP now owns 1,637,808 shares of the company's stock worth $113,336,000 after purchasing an additional 1,175,408 shares during the period. Finally, Hudson Bay Capital Management LP raised its position in shares of Henry Schein by 102.1% during the 4th quarter. Hudson Bay Capital Management LP now owns 1,465,007 shares of the company's stock worth $101,378,000 after purchasing an additional 740,007 shares during the period. Institutional investors own 96.62% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the company. Robert W. Baird reiterated a "neutral" rating and set a $72.00 price target (down from $82.00) on shares of Henry Schein in a research report on Monday. Piper Sandler lowered their target price on Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 30th. Wall Street Zen cut Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Baird R W cut Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday. Finally, Leerink Partners set a $75.00 target price on Henry Schein in a research report on Monday. Eight investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $78.36.

Check Out Our Latest Stock Analysis on HSIC

Henry Schein Price Performance

Shares of HSIC stock traded down $1.15 during mid-day trading on Wednesday, hitting $69.49. 1,443,557 shares of the stock traded hands, compared to its average volume of 1,745,619. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49. The firm has a market cap of $8.46 billion, a price-to-earnings ratio of 21.72, a price-to-earnings-growth ratio of 2.28 and a beta of 0.87. The company's 50-day simple moving average is $71.73 and its 200-day simple moving average is $71.33. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.75 and a current ratio of 1.38.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings results on Monday, May 5th. The company reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.04. Henry Schein had a return on equity of 14.87% and a net margin of 3.21%. The company had revenue of $3.17 billion for the quarter, compared to analysts' expectations of $3.24 billion. During the same period last year, the firm earned $1.10 EPS. The firm's revenue for the quarter was down .1% on a year-over-year basis. As a group, equities research analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Henry Schein Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Should You Invest $1,000 in Henry Schein Right Now?

Before you consider Henry Schein, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.

While Henry Schein currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Time to Cash Out? 5 Stocks to Drop Before Earnings
Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines